glp 1 law The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 GLP-1 supplements are everywhere—but do

The clinical data tells a more nuanced story: GLP-1 medications do not uniquely destroy muscle

Think sauerkraut, tempeh, kombucha and kefir

Whilst there are clear issues with calculating prevalence of AAS use, there exists a growing body of evidence to show a rise in presentations to health services by IPED users and a growing and widespread availability of AAS and other IPEDs (Brennan et al, 2017, McBride et al, 2018)

You can find a list below: More research is needed to understand why these happen and identify the factors that can help predict what will happen specifically

The main route of excretion is through the kidneys, in the form of urine